FDA Adverse Event
Injury
Summary report: N
LIGASURE IMPACT
MDR report key: 1853334
·
Received September 30, 2010
Report
- Report Number
- 1717344-2010-00677
- Event Type
- Injury
- Date Received
- September 30, 2010
- Date of Event
- September 8, 2010
- Report Date
- September 24, 2010
- Manufacturer
- COVIDIEN LP (VALLEYLAB)
- Product Code
- GEI
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- OTHER
Narratives
Additional Manufacturer Narrative · 1
(B)(4). THE SITE INDICATED THAT THE INCIDENT SAMPLE WAS DISCARDED. IF ADDITIONAL INFO PERTINENT TO THE INCIDENT IS OBTAINED, A FOLLOW-UP REPORT WILL BE SUBMITTED.
Description of Event or Problem · 1
THE CUSTOMER REPORTED THAT THEY PERFORMED HEMIGASTRECTOMY BILLROTH II PROCEDURE ON A PT WITH NO ABNORMAL OCCURRENCES NOTED DURING THE SURGERY. THE PT INCURRED POSTOPERATIVE BLEEDING SEVERAL DAYS AFTER SURGERY. AN ADDITIONAL SURGERY WAS PERFORMED, AND THE SURGEON USED LIGATION TO SEAL THE VESSEL. THE CUSTOMER HAS INDICATED THAT THE HANDPIECE FOR THIS INCIDENT HAS BEEN DISCARDED. THE PT IS REPORTED AS DOING FINE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | LIGASURE IMPACT | LIGASURE VESSEL SEALING SYSTEM | GEI | COVIDIEN LP (VALLEYLAB) | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | UNK | Other| R | FORCE TRIAD ENERGY PLATFORM |